Investing in drug safety monitoring could avoid complications - and save medical costs
world Pharma News | May 17, 2017
Increased investment in "pharmacovigilance surveillance" - systems to proactively monitor safety problems with new medications - has the potential to avoid harmful drug effects while lowering healthcare costs, according to a study in the June issue of Medical Care. The journal is published by Wolters Kluwer.